-+ 0.00%
-+ 0.00%
-+ 0.00%

LUNDBECK RECEIVES FDA FAST TRACK DESIGNATION FOR LU AH69593, AN INVESTIGATIONAL OREXIN 2 RECEPTOR AGONIST FOR NARCOLEPSY

Reuters·07/23/2026 07:30:00

Please log in to view news